Joseph Edelman - Net Worth and Insider Trading

Joseph Edelman Net Worth

The estimated net worth of Joseph Edelman is at least $6 Million dollars as of 2023-09-24. Joseph Edelman is the Director, 10% Owner of Athira Pharma Inc and owns about 3,114,805 shares of Athira Pharma Inc (ATHA) stock worth over $6 Million. Details can be seen in Joseph Edelman's Latest Holdings Summary section.

Transaction Summary of Joseph Edelman


Joseph Edelman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Joseph Edelman owns 48 companies in total, including ARYA Sciences Acquisition Corp II (ARYBU) , Athira Pharma Inc (ATHA) , and Quotient Ltd (QTNTQ) among others .

Click here to see the complete history of Joseph Edelman’s form 4 insider trades.

Insider Ownership Summary of Joseph Edelman

Ticker Comapny Transaction Date Type of Owner
ARYBU ARYA Sciences Acquisition Corp II 2020-10-20 director
ATHA Athira Pharma Inc 2021-01-25 director & 10 percent owner
QTNTQ Quotient Ltd 2018-12-07 10 percent owner
ATNXQ Athenex Inc 2019-05-03 10 percent owner
ALBO Albireo Pharma Inc 2020-02-03 10 percent owner
ARYA ARYA Sciences Acquisition Corp III 2020-08-06 director
ALDX Aldeyra Therapeutics Inc 2020-07-09 10 percent owner
LPTX Leap Therapeutics Inc 2020-03-09 10 percent owner
SLDB Solid Biosciences Inc 2018-01-25 10 percent owner
VYNE VYNE Therapeutics Inc 2020-03-09 director & 10 percent owner
MGTX MeiraGTx Holdings PLC 2019-06-19 10 percent owner
LYRA Lyra Therapeutics Inc 2020-04-30 director & 10 percent owner
VBIV VBI Vaccines Inc 2018-12-13 10 percent owner
CRNX Crinetics Pharmaceuticals Inc 2020-04-17 10 percent owner
ADMA ADMA Biologics Inc 2019-05-21 10 percent owner
AGRX Agile Therapeutics Inc 2019-03-04 10 percent owner
KDMN Kadmon Holdings Inc 2019-11-18 10 percent owner
DOVA Dova Pharmaceuticals Inc 2019-11-12 10 percent owner
FOMX Foamix Pharmaceuticals Ltd 2019-07-29 10 percent owner
MOTS Motus GI Holdings Inc 2018-02-14 10 percent owner
FOLD Amicus Therapeutics Inc 2018-09-12 10 percent owner
LJPC La Jolla Pharmaceutical Co 2019-01-07 10 percent owner
CORI Corium International Inc 2018-10-11 10 percent owner
ARYAU ARYA Sciences Acquisition Corp 2018-10-05 director
ZGNX Zogenix Inc 2018-08-10 10 percent owner
VRCA Verrica Pharmaceuticals Inc 2018-06-14 10 percent owner
GBT Global Blood Therapeutics Inc 2017-12-14 10 percent owner
ARAV Aravive Inc 2017-09-21 10 percent owner
ACRX AcelRx Pharmaceuticals Inc 2017-06-19 10 percent owner
AEGR Aegerion Pharmaceuticals Inc 2013-06-15 10 percent owner
XTLB XTL Biopharmaceuticals Ltd 2008-01-03 10 percent owner
ANIP ANI Pharmaceuticals Inc 2003-08-04 10 percent owner
ATRS Antares Pharma Inc 2004-02-06 10 percent owner
PTN Palatin Technologies Inc 2003-05-29 10 percent owner
SCYX SCYNEXIS Inc 2020-12-21 10 percent owner
ATXS Astria Therapeutics Inc 2021-01-28 director & 10 percent owner
ISO IsoPlexis Corp 2021-10-07 10 percent owner
RXDX Prometheus Biosciences Inc 2021-03-11 10 percent owner
RAIN Rain Oncology Inc 2021-04-22 10 percent owner
LABP Landos Biopharma Inc 2021-08-27 director
CERE Cerevel Therapeutics Holdings Inc 2020-10-20 director
NAUT Nautilus Biotechnology Inc 2021-12-08 10 percent owner
LIAN LianBio 2021-10-29 10 percent owner
ARYD ARYA Sciences Acquisition Corp IV 2021-02-25 director
ARYE ARYA Sciences Acquisition Corp V 2021-07-12 director
ACRV Acrivon Therapeutics Inc 2022-11-17 10 percent owner
CEMI Chembio Diagnostics Inc 2023-04-04 10 percent owner
SLNO Soleno Therapeutics Inc 2023-05-19 10 percent owner

Joseph Edelman Latest Holdings Summary

Joseph Edelman currently owns a total of 1 stock. Joseph Edelman owns 3,114,805 shares of Athira Pharma Inc (ATHA) as of September 22, 2020, with a value of $6 Million.

Latest Holdings of Joseph Edelman

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ATHA Athira Pharma Inc 2020-09-22 3,114,805 1.98 6,167,314

Holding Weightings of Joseph Edelman

Joseph Edelman Form 4 Trading Tracker

According to the SEC Form 4 filings, Joseph Edelman has made a total of 1 transactions in Athira Pharma Inc (ATHA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Athira Pharma Inc is the acquisition of 1,058,824 shares on September 22, 2020, which cost Joseph Edelman around $18 Million.

Insider Trading History of Joseph Edelman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Joseph Edelman Trading Performance

GuruFocus tracks the stock performance after each of Joseph Edelman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Joseph Edelman is 103.06%. GuruFocus also compares Joseph Edelman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Joseph Edelman within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Joseph Edelman's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Joseph Edelman

Average Relative Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) 20.72 103.06 14.17 -40.6 -55.62 -50.82
Relative Return to S&P 500(%) 16.56 91.85 -4.68 -73.18 -62.08 -60.04

Joseph Edelman Ownership Network

Ownership Network List of Joseph Edelman

No Data

Ownership Network Relation of Joseph Edelman

Joseph Edelman Owned Company Details

What does ARYA Sciences Acquisition Corp II do?

ARYA Sciences Acquisition Corp II is a blank check company.

Who are the key executives at ARYA Sciences Acquisition Corp II?

Joseph Edelman is the director of ARYA Sciences Acquisition Corp II. Other key executives at ARYA Sciences Acquisition Corp II include director & Chief Executive Officer Adam Leo Stone , director & Chief Financial Officer Michael Seth Altman , and 10 percent owner Arya Sciences Holdings Ii .

ARYA Sciences Acquisition Corp II (ARYBU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of ARYA Sciences Acquisition Corp II (ARYBU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ARYA Sciences Acquisition Corp II (ARYBU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ARYA Sciences Acquisition Corp II (ARYBU)'s detailed insider trading history can be found in Insider Trading Tracker table.


ARYA Sciences Acquisition Corp II Insider Transactions

No Available Data

Joseph Edelman Mailing Address

Above is the net worth, insider trading, and ownership report for Joseph Edelman. You might contact Joseph Edelman via mailing address: C/o Perceptive Advisors Llc, 51 Astor Place, 10th Floor, New York Ny 10003.

Discussions on Joseph Edelman

No discussions yet.